Please login to the form below

Not currently logged in
Email:
Password:

Unlicensed Avastin

This page shows the latest Unlicensed Avastin news and features for those working in and with pharma, biotech and healthcare.

Bayer to challenge Avastin legal ruling

Bayer to challenge Avastin legal ruling

of rows over unlicensed use of Avastin in AMD. ... Switching to off-licence Avastin would save £100m or more, if applied across the whole of England.

Latest news

  • NHS wins legal fight with pharma over off-label Avastin NHS wins legal fight with pharma over off-label Avastin

    A group of NHS organisations have claimed a legal victory against Bayer and Novartis, which had sought to stop them using Avastin as a cheap, unlicensed substitute for their ophthalmology drugs. ... The case could not only open the door for more

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....